WARNING: This product contains nicotine. Nicotine is an addictive chemical.

CDC: EVALI peaked last year; states no longer need to report monthly cases

The U.S. Centers for Disease Control and Prevention has announced that states no longer are required to report monthly the number their individual case numbers of the so-called “vaping related” lung disorder EVALI.  According to a recent CDC press release, cases of EVALI peaked way back in September 2019 – months before the press was forced by public pressure to implement a nationwide ban on flavored disposable like JUUL and VUSE.  Furthermore, only four cases of EVALI were reported in month of February 2020.

“Because of substantial declines in EVALI cases following their peak in September 2019, CDC discontinued the collection of EVALI case reports in February 2020. However, states could continue to collect data on EVALI cases. Because CDPH received reports of only four EVALI cases in February 2020, CDPH asked local jurisdictions to continue to report cases but discontinue active case interviews and follow-up at that time.”

This news is important because the U.S. House of Representatives is currently slated to approve an anti-vaping bill already passed by the Senate.  If signed into law by the President, S-153 will prohibit the federal postal service from delivering vaping products – both e-liquids and hardware to American vapers throughout the nation. 

Related Article:   With a whimper not a bang, CDC finally closes the case on ‘vaping related’ EVALI

There will be a legal loophole, however.  But its attached extra costs for the average consumer will be significant.  According to the bill, private delivery companies like UPS and FedEx will still be allowed to deliver vape products, but an in-person signature will be required along with the verification of age using a photo ID.  Compared to the U.S. Post Office, these private vendors typically charge substantially higher rates to the e-commerce vendors.  These additional costs will then be passed on the consumer resulting in a potential per-package increase of as high as 20 percent.

Congress to vote on anti-vaping bill S-153 any day now

Lawmakers began considering such a bill almost immediately after the initial outbreak of EVALI – which coincidentally - the mainstream media began reporting using fearmongering tactics just slightly after its September peak.  Furthermore, the CDC determined that the cause of EVALI is not nicotine-based vapes.  It was black market cartridges illegally enhanced with THC and vitamin E acetate. 

Unfortunately, the CDC only recently announced that the number of cases nationwide has been steadily declining for well over the last 9 months, and the mainstream media is, of course, failing to report this important information.  Regrettably, this means that the general public – and perhaps some congressional officials in Washington DC - are still under the false impression that EVALI remains a substantial health threat to American youth. 

Related Article: Blumenthal politicizes COVID-19 in nationwide push to ban vaping (not smoking)

It's time to inform the House of Representatives that they are about to sign a bill that is not only no longer needed but that will also severely jeopardized public health.  The U.S. vaping community should also contact President Trump immediately and demand that he refuse to sign S-153 into law should it pass the House. 

To contact the President, vapers can call the White House (202-456-1414), send a personal email (president@whitehouse.gov), or contact him directly on Twitter (@realdonaldtrump). To contact one’s individual congresspersons to make similar demands, the vaping advocacy group Consumer Advocates for Smoke-Free Alternatives Association (CASAA) has created an easy-to-use digital form located on the organization’s website.  CLICK HERE. 

Related Article:  Call to action: Congress set to vote on bill to ban vapes-by-mail

(Images courtesy of Shutterstock)

Leave a comment

Please note, comments must be approved before they are published